Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | PPARA | Q07869 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.44 |
| ▸ | THRA | P10827 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | PLK1 | P53350 | 1/20 | 0.44 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31301135 | 0.87 | LMNA (0.51) | CNR2KMT2APPARASMN1; SMN2TP53 | |
| SCHEMBL28412366 | 0.86 | LIPG (0.51) | PPARALIPG | |
| SCHEMBL31405271 | 0.86 | LIPG (0.51) | PPARALIPG | |
| SCHEMBL30526019 | 0.86 | LIPG (0.51) | PPARALIPG | |
| SCHEMBL29641999 | 0.86 | LIPG (0.51) | PPARALIPG | |
| SCHEMBL11002989 | 0.86 | LIPG (0.51) | PPARALIPG | |
| SCHEMBL1534314 | 0.86 | LIPG (0.51) | PPARALIPG | |
| SCHEMBL9559479 | 0.86 | LIPG (0.51) | PPARALIPG | |
| SCHEMBL28348884 | 0.86 | LIPG (0.51) | PPARALIPG | |
| SCHEMBL28891018 | 0.86 | LIPG (0.51) | PPARALIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090068126-A1 | Composition for surface photoprotection | SOARES ROMEIRO LUIZ ANTONIO | 2009-03-12 | — | — | US | disclosed |
| EP-1812027-A2 | COMPOUNDS CAPABLE OF ABSORBING ULTRAVIOLET RADIATION, COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THEIR PREPARATION | Universidade Federal Do Rio De Janeiro - UFRJ (BR) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006042391-A2 | PHOTOPROTECTIVE PHENOL DERIVATIVES OBTAINED FROM CASHEW NUT-SHELL LIQUID | UNIVERSIDADE FEDERAL DO RIO DE JANEIRO-UFRJ (BR) | 2006-04-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090068126-A1 | Composition for surface photoprotection | S100A10, CD63, S100A9 | CNR2 734/4885KMT2A 4334/4885PPARA 1792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.